학술논문
Continued 5α-reductase inhibitor use after prostate cancer diagnosis and the risk of reclassification and adverse pathological outcomes in the PASS
Document Type
Article
Author
Source
In: Journal of Urology . (Journal of Urology, 1 January 2019, 201(1):106-111)
Subject
Language
English
ISSN
15273792
00225347
00225347